Skip to main content
. 2021 Jun 23;22(13):6737. doi: 10.3390/ijms22136737

Figure 4.

Figure 4

Neuroprotection mediated by KYNA against neurotoxic effects of QUIN, mediated by microglia and astrocyte activation. Legend: PD—Parkinson’s disease, NMDA—N-methyl-D-aspartate receptor, KYNA—kynurenic acid, QUIN—quinolinic acid, increased expression.